|
|
|
|
|
|
by dontreact
1992 days ago
|
|
|
The general thread here is about AI helping with a more proactive approach to medicine. Screening for high risk populations certainly falls under that. You certainly said that screening leads to over diagnosis. I think for screening, the best results are probably the upcoming prospective study from Kheiron. https://www.kheironmed.com/news/press-release-new-results-sh... |
|
|
will show stronger performance. But Kheiron appears to be ahead as far as proving the value of the tool since they have actually validated prospectively.